Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson’s disease-Reference-Cited by-同舟云学术

Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson’s disease

Published:2016-01 Issue: Volume:103 Page:328-339
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Pinho Brígida R.^ORCID,Reis Sara D.,Guedes-Dias Pedro,Leitão-Rocha Ana,Quintas Clara,Valentão Patrícia,Andrade Paula B.,Santos Miguel M.,Oliveira Jorge M.A.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference66 articles.

1. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson’s disease?;Harrison;Pharmacol. Ther.,2013

2. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease and monogenic Parkinsonism;Hauser;Neurobiol. Dis.,2013

3. The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson’s disease;Van Laar;Neurobiol. Dis.,2013

4. Can cellular models revolutionize drug discovery in Parkinson’s disease?;Schüle;Biochim. Biophys. Acta,2009

5. Animal models of Parkinson’s disease: a source of novel treatments and clues to the cause of the disease;Duty;Br. J. Pharmacol.,2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases;Journal of Medicinal Chemistry;2024-09-10

2. Role of histone deacetylases and their inhibitors in neurological diseases;Pharmacological Research;2024-09

3. Role of histone deacetylase inhibitors in non-neoplastic diseases;Heliyon;2024-07

4. Nervonic acid suppresses MPTP-induced Parkinson's disease in an adult zebrafish model by regulating the MAPK/NF-κB signaling pathway, inflammation, apoptosis, and oxidative stress;Food Bioscience;2024-06

5. Edaravone counteracts redox and metabolic disruptions in an emerging zebrafish model of sporadic ALS;Free Radical Biology and Medicine;2024-05